| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.250 | 4.627 | 19.085 | 8.166 | 12.978 | 7.661 | 24.036 | 29.333 | 12.756 | 0 |
| Total Income - EUR | 19.837 | 18.098 | 12.253 | 21.146 | 34.701 | 22.929 | 38.350 | 35.745 | 22.145 | 5.988 |
| Total Expenses - EUR | 7.495 | 17.526 | 8.705 | 16.889 | 31.285 | 9.478 | 22.601 | 30.329 | 18.020 | 10.182 |
| Gross Profit/Loss - EUR | 12.342 | 572 | 3.547 | 4.257 | 3.416 | 13.452 | 15.749 | 5.417 | 4.125 | -4.194 |
| Net Profit/Loss - EUR | 12.125 | 213 | 2.975 | 4.175 | 3.286 | 13.375 | 15.508 | 5.123 | 3.465 | -4.194 |
| Employees | 0 | 0 | 0 | 2 | 2 | 1 | 2 | 2 | 0 | 0 |
Check the financial reports for the company - Biologica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.673 | 0 | 0 | 430 | 35.824 | 35.145 | 49.956 | 45.534 | 40.833 | 36.066 |
| Current Assets | 27.776 | 33.492 | 34.941 | 73.058 | 54.653 | 58.870 | 73.219 | 96.737 | 106.411 | 102.480 |
| Inventories | 16.915 | 15.425 | 5.663 | 12.637 | 5.971 | 5.857 | 16.299 | 30.702 | 30.609 | 30.162 |
| Receivables | 10.854 | 17.892 | 28.607 | 59.888 | 48.131 | 52.824 | 56.099 | 66.024 | 71.445 | 70.972 |
| Cash | 7 | 175 | 671 | 533 | 552 | 188 | 821 | 11 | 4.357 | 1.346 |
| Shareholders Funds | 20.034 | 20.043 | 22.681 | 27.027 | 25.432 | 38.325 | 52.983 | 58.271 | 61.559 | 57.021 |
| Social Capital | 45 | 45 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 14.415 | 13.449 | 12.260 | 14.221 | 47.839 | 52.967 | 70.192 | 84.000 | 85.684 | 81.526 |
| Income in Advance | 0 | 0 | 0 | 32.240 | 17.206 | 2.723 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "129 - 129" | |||||||||
| CAEN Financial Year |
129
|
|||||||||
Comments - Biologica Srl